APHARM SRL has a total of 48 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2007. It filed its patents most often in EPO (European Patent Office), Italy and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, medical technology and macromolecular chemistry and polymers are TIANJIN GOALGEN BIOTECHNOLOGY CO LTD, IVIEW THERAPEUTICS INC and AMRYT RES LIMITED.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 11 | |
#2 | Italy | 8 | |
#3 | WIPO (World Intellectual Property Organization) | 8 | |
#4 | United States | 5 | |
#5 | Canada | 4 | |
#6 | EAPO (Eurasian Patent Organization) | 4 | |
#7 | China | 3 | |
#8 | Australia | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Morocco | 1 | |
#11 | Mexico | 1 | |
#12 | Tunisia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Macromolecular chemistry and polymers | |
#4 | Basic materials chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Object sterilising | |
#4 | Coating compositions | |
#5 | Compounding ingredients | |
#6 | Implantable devices |
# | Name | Total Patents |
---|---|---|
#1 | Pizzoni Angelo | 43 |
#2 | Pizzoni Paolo | 27 |
#3 | Pozzi Paolo | 8 |
#4 | Guerra Emanuele | 6 |
#5 | Zanasi Tania | 3 |
#6 | Taurino Rosa | 3 |
#7 | Ferrari Alessio | 1 |
#8 | Paolo Pizzoni | 1 |
#9 | Angelo Pizzoni | 1 |
Publication | Filing date | Title |
---|---|---|
EP3810165A1 | Pharmaceutical and nutraceutical compositions and combinations comprising active ingredients useful in the treatment and prevention of hepatic pathologies and kits comprising them | |
WO2018167661A1 | Combination of active ingredients, compositions comprising it and their use in the treatment of sarcopenia | |
EA037070B1 | Combination of glycosaminoglycans and an antacid agent and composition thereof | |
ITUB20160024A1 | New topical compositions including usnic acid and their use in therapy. | |
US2018008626A1 | Combination of hyaluronic acid and macrogol and pharmaceutical compositions containing it | |
AU2015298457A1 | Elastomeric compositions comprising usnic acid and devices made thereof or coated therewith | |
CN105899233A | Combination of glycosaminoglycans and cyclodextrins | |
US2014107064A1 | Glycosaminoglycan oral use and compositions | |
EP2686029A1 | Method for making, by a sol-gel process, catheters including antibacteric coatings based on usnic acid | |
EA018333B1 | Glycosaminoglycan oral use and compositions | |
EP2155161A2 | Stable liquid composition of chondroitinsulfate and glucosamine |